- Home
- AARD vs NUAI Comparison
AARD vs NUAI Comparison
Compare AARD & NUAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AARD | NUAI |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.9M | 233.8M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | AARD | NUAI |
|---|---|---|
| Price | $13.38 | $4.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $30.63 | N/A |
| AVG Volume (30 Days) | 178.7K | ★ 7.0M |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $843,029.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 50.89 |
| 52 Week Low | $4.88 | $0.32 |
| 52 Week High | $19.58 | $12.29 |
Technical Indicators
Market Signals| Indicator | AARD | NUAI |
|---|---|---|
| Relative Strength Index (RSI) | 66.65 | 48.74 |
| Support Level | $9.18 | $3.87 |
| Resistance Level | $10.44 | $4.53 |
| Average True Range (ATR) | 0.91 | 0.61 |
| MACD | 0.46 | -0.07 |
| Stochastic Oscillator | 94.75 | 49.52 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About NUAI New Era Energy & Digital Inc. Common Stock
New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.